Vygon SA-医療機器分野:企業M&A・提携分析

◆英語タイトル:Vygon SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011941
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vygon SA (Vygon) is a medical specialty company that designs, manufactures and markets single use medical and surgical products. It offers products in the areas of paediatrics and neonatology, emergency and intensive care units, anaesthesia, support for post-operative pain relief, vascular access, surgery and home care. The company manufactures its products at plants in Europe, the US and Colombia. Vygon offers its products to healthcare professionals in hospital and independent practitioners. The company sells its products through a network of distributors and subsidiaries across the world. It has operations in North America, Europe, Asia Pacific, Middle East and Africa. Vygon is headquartered in Ecouen, France.

Vygon SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vygon SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Vygon SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Vygon SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Vygon SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Vygon SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Vygon SA, Medical Equipment, Deal Details 10
Partnerships 10
Almirall Enters into Licensing Agreement with Symatese 10
Curie-Cancer Extends Co-Development Agreement With Vygon 11
Vygon Enters Into Distribution Agreement With Ambu 12
Teleflex Enters Into Distribution Agreement With Perouse Medical 13
Acquisition 14
Vygon Acquires Perouse Medical 14
Vygon Acquires Medwin, Medical Device Company 15
Vygon SA – Key Competitors 16
Vygon SA – Key Employees 17
Vygon SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 21
Strategy And Business Planning 21
Feb 08, 2016: Vygon Group opens subsidiary in Finland 21
Corporate Communications 22
Jun 23, 2017: Vygon wins an international Business award for safe-enteral.com 22
Legal and Regulatory 23
Apr 30, 2016: New enteral nutrition connector of ISO 80369-3: a system presenting a real risk in premature infants and young children 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Vygon SA, Medical Equipment, Key Facts 2
Vygon SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Vygon SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Vygon SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Vygon SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Vygon SA, Deals By Market, 2011 to YTD 2017 8
Vygon SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Almirall Enters into Licensing Agreement with Symatese 10
Curie-Cancer Extends Co-Development Agreement With Vygon 11
Vygon Enters Into Distribution Agreement With Ambu 12
Teleflex Enters Into Distribution Agreement With Perouse Medical 13
Vygon Acquires Perouse Medical 14
Vygon Acquires Medwin, Medical Device Company 15
Vygon SA, Key Competitors 16
Vygon SA, Key Employees 17
Vygon SA, Other Locations 18
Vygon SA, Subsidiaries 18

★海外企業調査レポート[Vygon SA-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alexandria Real Estate Equities Inc:企業のM&A・事業提携・投資動向
    Alexandria Real Estate Equities Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alexandria Real Estate Equities Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • First Republic Private Wealth Management:企業の戦略・SWOT・財務情報
    First Republic Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary First Republic Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Navistar International Corporation (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corporation (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Uniqa Montenegro:企業の戦略・SWOT・財務情報
    Uniqa Montenegro - Strategy, SWOT and Corporate Finance Report Summary Uniqa Montenegro - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • European Medical Contract Manufacturing BV:医療機器:M&Aディール及び事業提携情報
    Summary European Medical Contract Manufacturing BV (EMCM BV), a subsidiary of Leader Biomedical Group, is a developer and manufacturer of sterile medicinal products. The company’s products include bone cements for hip and knee arthroplasty and vertebroplasty procedures; cement restrictors; human bon …
  • SDX Energy Inc (SDX):石油・ガス:M&Aディール及び事業提携情報
    Summary SDX Energy Inc (SDX), formerly Sea Dragon Energy Inc., is an independent upstream company. It carries out the exploration, development and production of crude oil and natural gas liquids. The company’s primary areas of focus are Morocco and Egypt. Its principal operations are currently conce …
  • Lamprell Plc (LAM):企業の財務・戦略的SWOT分析
    Lamprell Plc (LAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • City National Wealth Management:企業の戦略・SWOT・財務情報
    City National Wealth Management - Strategy, SWOT and Corporate Finance Report Summary City National Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Telenet Group Holding NV:企業の戦略・SWOT・財務分析
    Telenet Group Holding NV - Strategy, SWOT and Corporate Finance Report Summary Telenet Group Holding NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ceres Nanosciences Inc:製品パイプライン分析
    Summary Ceres Nanosciences Inc (Ceres Nanosciences) is a provider of sample preparation products and diagnostic tests. The company offers Nanotrap particles for research and development and Nanotrap lyme antigen test that are protein enrichment toolset that can be integrated seamlessly into any exis …
  • Synopsys, Inc.:企業のM&A・事業提携・投資動向
    Synopsys, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Synopsys, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Petro Matad Ltd (MATD):企業の財務・戦略的SWOT分析
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • JSC IC Allianz:企業の戦略・SWOT・財務分析
    JSC IC Allianz - Strategy, SWOT and Corporate Finance Report Summary JSC IC Allianz - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Svenska Petroleum Exploration AB:石油・ガス:M&Aディール及び事業提携情報
    Summary Svenska Petroleum Exploration AB (Svenska Petroleum), a subsidiary of Petroswede AB is an oil and gas company that offers offshore oil exploration and production. The company operates 3D Sendji data and acquisition of new 3D data in Kaba area to explore for the pre-salt. It has oil and gas p …
  • Electricity Generating Authority of Thailand:企業の戦略・SWOT・財務情報
    Electricity Generating Authority of Thailand - Strategy, SWOT and Corporate Finance Report Summary Electricity Generating Authority of Thailand - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Oxurion NV (THR):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreo …
  • Mediq NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediq NV (Mediq) is a provider of medical devices, pharmaceuticals and related care services. It offers these services directly to people’s homes (direct), through professional healthcare customers such as hospitals and care institutions (institutional), through wholesalers or through Mediq …
  • Chimerix Inc (CMRX):企業の財務・戦略的SWOT分析
    Summary Chimerix Inc (Chimerix) is a bio pharmaceutical company that develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s brincidofovir, an oral nucleotide analog to treat dsDNA viruses, adenovirus, cytomegalovirus, BK virus and herpes simplex viruses. Chimeri …
  • UTS Biogastechnik GmbH:企業の戦略的SWOT分析
    UTS Biogastechnik GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆